Insmed (INSM) Cash & Current Investments (2010 - 2026)

Insmed's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 2.01% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 2.01% YoY), while the FY2025 annual figure was $1.4 billion, changed 0.26% from the prior year.
• Cash & Current Investments was $1.2 billion for Q1 2026 at Insmed, down from $1.4 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $1.9 billion in Q2 2025 to a low of $513.3 million in Q3 2022.
• Historically, Cash & Current Investments has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 40.35% in 2024, then surged 101.34% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $1.1 billion in 2022, then tumbled by 32.03% to $780.4 million in 2023, then surged by 83.72% to $1.4 billion in 2024, then decreased by 0.26% to $1.4 billion in 2025, then fell by 14.44% to $1.2 billion in 2026.
• The last three Cash & Current Investments figures came in at $1.2 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.